Get started
Author

Rachel Powell

Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P 1 ) and receptor‐5 (S1P 5 ) agonist with autoimmune disease‐modifying activity
2016 · F L Scott, B Clemons, et al. · British Journal of Pharmacology · 317
PDF
Unique Contributors to the Curriculum: From Research to Practice for Speech-Language Pathologists in Schools
2018 · Rachel K. Powell · Language Speech and Hearing Services in Schools · 59
Single‐fraction spine SBRT end‐to‐end testing on TomoTherapy, Vero, TrueBeam, and CyberKnife treatment platforms using a novel anthropomorphic phantom
2015 · John J. Gallo, Isaac Kaufman, et al. · Journal of Applied Clinical Medical Physics · 40
PDF
Maximizing Student Outcomes in Schools: Data-Driven Individualized Education Program Goals and Objectives Aligned to the Standards
2023 · Rachel Powell, Jennifer Schultz, et al. · Language Speech and Hearing Services in Schools · 19
PDF
Tutorial: Data Collection and Documentation Strategies for Speech-Language Pathologist/Speech-Language Pathology Assistant Teams
2022 · Jennifer Schultz, Rachel Powell, et al. · Language Speech and Hearing Services in Schools · 15
Building Global Health Systems Capacity During COVID-19 to Improve Vaccination Access and Reduce Hesitancy: Case Studies in Zambia and Tanzania
2023 · Hailey S. Bednar, Ramot Adeboyejo, et al. · Health Security · 9
After a CEDAW Optional Protocol Inquiry into abortion law: a conversation with activists for change in Northern Ireland
2022 · Claire Pierson, Fiona Bloomer, et al. · International Feminist Journal of Politics · 8
PDF
An intra-action review conducted by the CDC Foundation during COVID-19 to evaluate emergency response procedures
2023 · H. Bednar, S. McMillan, et al. · Public Health · 7
218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib
2024 · Judy Tabbakh, Racha Kussaibati, et al. · Lung Cancer · 6
Metabolites of RPC1063 Contribute to In Vivo Efficacy (P05.157)
2013 · Fiona Scott, Gregg Timony, et al. · Neurology · 5
A Note on Marginality
2002 · Rachel Powell, John Clarke · Routledge eBooks · 5
Sa1221 Rpc1063, a Potent, Selective S1P1 Receptor Modulator, Is Active in a Therapeutic IBD Model and Exhibits Favorable PK/PD Properties in Healthy Volunteers
2013 · Jennifer Brooks, Robert J. Peach, et al. · Gastroenterology · 3
Addressing immediate public health needs as part of Afghan evacuees’ resettlement to the United States during the COVID-19 pandemic
2023 · H. Bednar, R. Powell, et al. · Public Health · 2
Building international infection prevention and control capacity during COVID-19: Case studies from Ethiopia and Indonesia
2023 · Hailey Bednar, Ramot Adeboyejo, et al. · Journal of Global Health · 1
PDF
Predictors of Mortality in End-Stage Renal Disease Patients With Infective Endocarditis
2015 · Rachel Powell, James P. Steinberg, et al. · Open Forum Infectious Diseases · 1
Single Fraction Stereotactic Body Radiation Therapy (SBRT) for Spine Metastasis: A Dosimetric Comparison of Multiple Treatment Delivery Systems
2013 · I. Kaufman, S. Pandya, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
The Preclinical Safety Profile of RPC1063, a Selective and Potent Sphingosine 1-Phosphate 1 Receptor (S1P1R) Agonist (P01.158)
2013 · Gregg Timony, Jennifer Brooks, et al. · Neurology · 1
358 A Small Molecule S1P1 Receptor Agonist With Significant Efficacy in Animal Models of Inflammatory Bowel Disease (IBD)
2012 · Bryan Clemons, Harry Dedman, et al. · Gastroenterology · 1
A note on marginality
2010 · Rachel Powell, John Clarke · Taylor & Francis eBooks · 1
Review of the School Meals Service and Other School Nutritional Issues in Wales. Final Report.
2006 · Jackie Nicholas, Rachel Powell, et al. · National Foundation for Educational Research · 1
250 Real-World Efficacy Data on First-Line Atezolizumab Plus Chemotherapy in Extensive Small Cell Lung Cancer (ES-SCLC): A Multi-Centre Retrospective Analysis from University Hospitals Birmingham NHS Trust and Worcester Acute Hospitals NHS Trust
2026 · Hemalatha Neralla, Rachel Powell, et al. · Lung Cancer
152 AERATE-lung: management and prophylaxis of EGFR inhibitor skin adverse events in NSCLC: variations between dermatologists and oncology teams in the UK
2026 · Thomas Newsom-Davis, Rachel Powell, et al. · Lung Cancer
Evaluation of the use of next generation sequencing for directing treatment for patients with advanced non-small cell lung cancer (NSCLC): a single centre experience from University Hospitals Birmingham NHS Foundation Trust (UHB)
2022 · Racha Kussaibati, Emily Plummer, et al. · Lung Cancer
The student movement
2022 · Rachel Powell, Hamsavani Rajeswaren · Bloomsbury Academic eBooks
Whispered conversations: Disability and abortion
2022 · Rachel Powell, Jakki Hanlon, et al. · Bloomsbury Academic eBooks
Works count: 30
Citation count: 502
H-index: 7
I10-index: 5
Year
Topic
Type